Home Cart Sign in  
Chemical Structure| 80306-38-3 Chemical Structure| 80306-38-3

Structure of AR7
CAS No.: 80306-38-3

Chemical Structure| 80306-38-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AR7 is a retinoic acid receptor α (RARα) antagonist.

Synonyms: AR7

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AR7

CAS No. :80306-38-3
Formula : C15H12ClNO
M.W : 257.71
SMILES Code : CC1=CC=C(C2=NC3=CC=C(Cl)C=C3OC2)C=C1
Synonyms :
AR7
MDL No. :MFCD27978377
InChI Key :MVOZLTFXYGHZPM-UHFFFAOYSA-N
Pubchem ID :44250175

Safety of AR7

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H361-H372-H410
Precautionary Statements:P201-P264-P280-P301+P330+P331-P312
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse Primary Cortical Neurons 10 μM and 20 μM 21 days AR7 treatment significantly reduced the accumulation of SNCA oligomers in LRRK2 KI neurons, indicating that AR7 can suppress oligomer formation. PMC6984454
mouse primary hepatocytes 10 µM 24 hours Pharmacological activation of CMA by AR7 treatment increased LAMP2A expression, leading to NCoR1 degradation. PMC10448198
Mouse primary hepatocytes 300 µM 24 hours To evaluate the effect of AR7 on diclofenac-induced lipid accumulation, results showed that AR7 reversed the diclofenac-induced lipid accumulation. PMC8899581
HepG2 cells 10 µM 24 hours To evaluate the effect of AR7 on diclofenac-induced CMA inhibition, results showed that AR7 reversed the diclofenac-induced CMA inhibition. PMC8899581
OLN-93 cells 40 μM 16 hours To verify the induction of CMA activity by AR7, results showed increased LAMP2A-positive lysosomes, indicating enhanced CMA activity PMC9466620
OLN-AS7 cells 40 μM 48 hours AR7 treatment significantly reduced human SNCA protein levels, indicating that CMA enhancement facilitates SNCA clearance PMC9466620
OLN-p25α cells 40 μM 48 hours AR7 treatment significantly reduced TPPP/p25A protein levels, indicating that CMA enhancement facilitates TPPP/p25A clearance PMC9466620
testicular tissue 10, 20, 50 μMol/L 24, 48, 72 hours To determine the optimal concentration and exposure time of AR7, the results showed that 20 μMol/L AR7 for 48 hours was the optimal condition. PMC9293722

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Diclofenac-induced hepatic steatosis model Intraperitoneal injection 30 mg/kg 7 days To evaluate the effect of AR7 on diclofenac-induced hepatic steatosis, results showed that AR7 significantly alleviated hepatic steatosis and liver injury. PMC8899581

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.88mL

0.78mL

0.39mL

19.40mL

3.88mL

1.94mL

38.80mL

7.76mL

3.88mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories